This is the new MLex platform. Existing customers should continue to use the existing MLex platform until migrated.
For any queries, please contact Customer Services or your Account Manager. Dismiss

Alcon, STAAR Surgical get antitrust clearance in US

By Flavia Fortes ( September 30, 2025, 14:37 GMT | Insight) -- Alcon and STAAR Surgical have received green light from the US antitrust authorities for their $1.5 billion deal, but the transaction still requires approval from China and Japan, among others. The companies continue to expect the transaction will close within six to 12 months of the initial merger agreement, subject to customary closing conditions, including regulatory approval and approval by STAAR’s stockholders. Alcon and STAAR Surgical have received green light from the US antitrust authorities for their $1.5 billion deal, but the transaction still requires approval from China and Japan, among others....

Prepare for tomorrow’s regulatory change, today

MLex identifies risk to business wherever it emerges, with specialist reporters across the globe providing exclusive news and deep-dive analysis on the proposals, probes, enforcement actions and rulings that matter to your organization and clients, now and in the longer term.


Know what others in the room don’t, with features including:

  • Daily newsletters for Antitrust, M&A, Trade, Data Privacy & Security, Technology, AI and more
  • Custom alerts on specific filters including geographies, industries, topics and companies to suit your practice needs
  • Predictive analysis from expert journalists across North America, the UK and Europe, Latin America and Asia-Pacific
  • Curated case files bringing together news, analysis and source documents in a single timeline

Experience MLex today with a 14-day free trial.

Start Free Trial

Already a subscriber? Click here to login